BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato Gel .015%

  Picato Gel (ingenol mebutate) 0.015% is indicated for the topical treatment of actinic keratosis.

  October 25, 2017

   · 

  4 min read
• BioForest

  Alligator Bioscience Aptevo Therapeutics: Tumor Antigen 5T4 Associated with Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527

  Alligator Bioscience and Aptevo today announced further details of the companies’ collaboration on ALG.APV-526, a bispecific antibody targeting 4-1BB and a tumor antigen, now identified as 5T4, which is found on various types of cancer cells.

  October 25, 2017

   · 

  6 min read
• FDA

  Ortek Therapeutics Announces FDA Clearance For Breakthrough Electronic Cavity Detection Device

  Ortek Therapeutics today announced that the Ortek ECD received FDA clearance from the FDA.

  October 25, 2017

   · 

  3 min read
• Business

  Amerigen and Biophore Collaborate on Penicillamine Generics

  Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant’s Cuprimine and other penicillamine based generic products to the U.S. market using active pharmaceutical ingredient supplied by Biophore from India.

  October 25, 2017

   · 

  1 min read
• Business

  Milestone Pharma Appoints Lorenz Muller as Chief Commercial Officer

  Milestone Pharmaceuticals USA today announced the appointment of Lorenz Muller as CCO.

  October 25, 2017

   · 

  3 min read
• Business

  Parkinson’s Foundation Welcomes Two New Board Members

  The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

  October 25, 2017

   · 

  2 min read
• Business

  Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases

  The Michael J. Fox Foundation for Parkinson’s Research and the Tau Consortium today announce a funding partnership to accelerate development of novel PET imaging tracers for the detection of the alpha-synuclein and tau proteins in the living brain.

  October 25, 2017

   · 

  4 min read
• Business

  Array Biopharma to Report Financial Results for the First Quarter of Fiscal 2018 On October 31, 2017

  Array BioPharma will report financial results for the first quarter of fiscal 2018 and hold a conference call to discuss those results on Tuesday, October 31, 2017.

  October 25, 2017

   · 

  1 min read
• Genetown

  Landmark Study Evaluates Long-Term Results of BTL Vanquish Technology Four Years Post-Treatment

  BTL Aesthetics is excited to share the findings of a newly published study that boasts long lasting benefits of noninvasive, radiofrequency energy-as used in the breakthrough BTL Vanquish and Vanquish ME devices-to achieve abdominal circumferential reduction.

  October 25, 2017

   · 

  2 min read
• CathWorks Announces FAST-FFR Pivotal Clinical Trial

  Cathworks announced today that the first patient has been enrolled in the FAST-FFR clinical trial.

  October 25, 2017

   · 

  2 min read